Zhengxing Qu

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

Josette Carnahan, Rhona Stein, Zhengxing Qu et al. · Molecular Immunology · 2006 · 174 citations

Pharmacy, Immunology, Oncology +14

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

Rhona Stein, Zhengxing Qu, Susan Chen et al. · Clinical Cancer Research · 2004 · 170 citations · Full text

Pharmacy, Immunology, Oncology +17

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

Puja Sapra, Rhona Stein, J. Pickett et al. · Clinical Cancer Research · 2005 · 169 citations

Medicine, Oncology, Pharmacology +17

Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies

Rhona Stein, Zhengxing Qu, Thomas M. Cardillo et al. · Blood · 2004 · 148 citations · Full text

Pharmacy, Immunology, Oncology +16

Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action

Zhengxing Qu, David M. Goldenberg, Thomas M. Cardillo et al. · Blood · 2007 · 55 citations · Full text

Medicine, Immunology, Oncology +10